Combining Degradable Starch Microspheres and Angiotensin II for Drug Delivery in Colorectal Cancer
Author Information
Author(s): R. Carter, T.G. Cooke, D. Hemingway, C.S. McArdle, W. Angerson
Primary Institution: University Department of Surgery, Glasgow Royal Infirmary
Hypothesis
Can the combination of degradable starch microspheres and angiotensin II enhance drug delivery to liver tumors?
Conclusion
The combination of degradable starch microspheres and angiotensin II significantly improved drug retention in liver tumors compared to controls.
Supporting Evidence
- Degradable Starch Microspheres alone significantly increased marker retention in liver and tumor.
- The combination treatment resulted in a significantly improved tumor to liver ratio.
- The study confirmed previous findings that both treatments can enhance drug delivery.
Takeaway
This study found that using two treatments together can help deliver medicine better to liver tumors in rats.
Methodology
The study used a rat model to compare drug delivery methods involving degradable starch microspheres and angiotensin II.
Limitations
The study was conducted in an animal model, which may not fully replicate human responses.
Participant Demographics
Male Hooded Lister rats, weight 200-250 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website